首页> 外文期刊>Chemical research in toxicology >Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.
【24h】

Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.

机译:使用加速器质谱对生物样品中的3H进行原子检测:结合14C加速器质谱在低剂量,双同位素示踪剂研究中的应用。

获取原文
获取原文并翻译 | 示例
       

摘要

This is the first demonstration of the use of accelerator mass spectrometry (AMS) as a tool for the measurement of 3H with attomole (10(-18) mol) sensitivity in a biological study. AMS is an analytical technique for quantifying rare isotopes with high sensitivity and precision and has been most commonly used to measure 14C in both the geosciences and more recently in biomedical research. AMS measurement of serially diluted samples containing a 3H-labeled tracer showed a strong correlation with liquid scintillation counting. The mean coefficient of variation of 3H AMS based upon the analysis of separately prepared aliquots of these samples was 12%. The sensitivity for 3H detection in tissue, protein, and DNA was approximately 2-4 amol/mg of sample. This high sensitivity is comparable to detection limits for 14C-labeled carcinogens using 14C AMS and demonstrates the feasibility of 3H AMS for biomedical studies. One application of this technique is in low-dose, dual-isotope studies in conjunction with 14C AMS. We measured the levels of 3H-labeled 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 14C-labeled 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in rat liver tissue and bound to liver DNA and protein 4.5 h following acute administration of individual or coadministered doses in the range of 4-5100 pmol/kg of body weight. Levels of PhIP and MeIQx in whole tissue and bound to liver protein were dose-dependent. MeIQx-protein and -DNA adduct levels were higher than PhIP adduct levels, which is consistent with their respective carcinogenicity in this organ. Coadministration of PhIP and MeIQx did not demonstrate any measurable synergistic effects compared to administration of these compounds individually. These studies demonstrate the application of AMS for the low-level detection of 3H in small biological samples and for its use in conjunction with 14C AMS for dual-labeling studies.
机译:这是在生物学研究中使用加速器质谱(AMS)作为检测3H并具有attomole(10(-18)mol)敏感性的工具的首次演示。 AMS是一种用于高灵敏度和高精度地定量稀有同位素的分析技术,在地球科学和最近的生物医学研究中最常用于测量14C。含有3H标记示踪剂的系列稀释样品的AMS测量显示与液体闪烁计数密切相关。基于这些样品的单独制备的等分试样的分析,3H AMS的平均变异系数为12%。在组织,蛋白质和DNA中进行3H检测的灵敏度约为2-4 amol / mg样品。这种高灵敏度可与使用14C AMS进行14C标记致癌物的检测极限相媲美,并证明了3H AMS在生物医学研究中的可行性。此技术的一种应用是与14C AMS一起用于低剂量双同位素研究。我们测量了3H标记的2-氨基-1-甲基-6-苯基咪唑[4,5-b]吡啶(PhIP)和14C标记的2-氨基-3,8-二甲基咪唑[4,5-f]的水平急性施用个别或共同施用剂量在4-5100 pmol / kg体重范围内4.5小时后,大鼠肝脏组织中的喹喔啉(MeIQx)与肝脏DNA和蛋白质结合。整个组织中与肝脏蛋白结合的PhIP和MeIQx的水平是剂量依赖性的。 MeIQx-蛋白质和-DNA加合物的水平高于PhIP加合物的水平,这与其在该器官中各自的致癌性相一致。与单独给药这些化合物相比,PhIP和MeIQx的共同给药未显示任何可测量的协同作用。这些研究证明了AMS在小型生物样品中低水平检测3H的应用,以及与14C AMS一起用于双标记研究的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号